High titer, prostate specific antigen-specific human IgG production by hu-PBL-SCID mice immunized with antigen-mouse IgG2a complex-pulsed autologous dendritic cells

Journal of Immunology

Volumn 161, Issue 10, 1998, Pages 5772-5780

  Coccia, Marco A ^a   Brams, Peter ^a  

^a BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G2A; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; COMBINED IMMUNODEFICIENCY; DENDRITIC CELL; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANIMALS; ANTIBODY SPECIFICITY; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DENDRITIC CELLS; EPITOPES; FEMALE; HUMANS; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOPHENOTYPING; MACROMOLECULAR SUBSTANCES; MALE; MICE; MICE, INBRED ICR; MICE, SCID; PROSTATE-SPECIFIC ANTIGEN;

EID: 0032533820     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Bosma, M. J., and A. M. Carroll. 1991. The scid mouse mutant: definition, characterization and potential uses. Annu. Rev. Immunol. 9:323.
2. Brams, P., M.-L. Nguyen, S. Chamat, I. Royston, and P. R. Morrow. 1998. Antigen-specific IgG responses from naive human splenocytes: in vitro priming followed by antigen boost in the SCID mouse. J. Immunol. 160:2051.
3. Coccia, M. A., S. Weeks, K. Knott, and K. Kuus-Reichel. 1998. Endogenous IL-6 enhances lymphocyte engraftment but not antibody production in SCIDhu PBL mice. Immunobiology 198:396.
4. Walker, W., and G. Gallagher. 1994. The in vivo production of specific human antibodies by vaccination of human-PBL-SCID mice. Immunology 83:163.
5. Mosier, D. E. 1991. Adoptive transfer of human lymphoid cells to severely immunodeficient mice, models for normal human immune function, autoimmunity, lymphomagenesis and AIDS. Adv. Immunol. 50:303.
6. Ifversen, P., C. Martensson, L. Danielsson, C. Ingvar, R. Carlsson, and C. A. K. Borrebaek. 1995. Induction of primary antigen-specific immune responses in SCID-hu-PBL mice by coupled T-B epitopes. Immunology 84:111.
7. Uchibayashi, N., R. Sasada, A. Shino, M. Okada, Y. Ohkubo, T. Ochi, and O. Shiho. 1995. A human monoclonal antibody to human self-antigen, CD2, derived from human peripheral blood lymphocytes engrafted in SCID mice. Hybridoma 14:313.
8. Williams, S. S., F.-A. Chen, H. Kida, S. Yokota, K. Miya, M. Kato, M. Barcos, H. Wang, T. Alosco, T. Umemoto, et al. 1996. Engraftment of human tumor-infiltrating lymphocytes and production of anti-tumor antibodies in SCID mice. J. Immunol. 156:1908.
9. Cella, M. F., Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10.
10. Peters, J. H., R. Gieseler, B. Theile, and F. Steinbach. 1996. Dendritic cells: from ontogenic orphans to myelomonocytic descendants. Immunol. Today 17:273.
11. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell precursors in human blood. J. Exp. Med. 180:83.
12. + T cells and process soluble antigen. J. Immunol. 155:5427.
13. Santiago-Schwartz, F., K. Laky, and S. E. Carson 1995. Stem cell factor enhances dendritic cell development. Adv. Exp. Med. Biol. 378:7.
14. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J. A. Ledbetter. 1991. Binding of the B cell activation antigen B7.1 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
15. Caux, C., B. Vanbervleit, C. Massacrier, M. Azuma, K. Okumura, L. Lanier, and J. Banchereau. 1994. B70/B7.2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180:1841.
16. Bakker, A. B. H., G. Marland, A. J. de Boer, R. J. F. Huijbens, E. H. J. Danen, G. J. Adema, and C. G. Figdor. 1995. Generation of cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen derived epitopes by dendritic cells in vitro. Cancer Res. 55:5330.
17. Van Elsas, A., S. H. Van der Burg, C. E. Van der Minne, M. Borhi, J. S. Mourer, C. J. M. Melief, and P. I. Schrier. 1996. Peptide pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stable HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen. Eur. J. Immunol. 26:1683.
18. Tjoa, B., A. Boynton, G. Kenny, H. Ragde, S.L. Misrock, and G. Murphy. 1996. Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity. Prostate 28:65.
19. Tjoa, B. A., S. J. Erickson, V. A. Bowes, H. Ragde, G. M. Kenny, O. E. Cobb, R. C. Ireton, M. J. Troychak, A. L. Boyton, and G. P. Murphy. 1997. Follow up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PMSA peptides. Prostate 32:277.
20. Fanger, N. A., K. Wardell, L. Shen, T. Tedder, and P. M. Guyre. 1996. Type I (CD64) and type II (CD32) FcγR receptor-mediated phagocytosis by human blood dendritic cells. J. Immunol. 157:541.
21. Fanger, N., D. Voigtlaender, C. Liu, S. Swink, K. Wardwell, J. Fisher, R. F. Graziano, C. Pfefferkorn, and P. M. Guyre. 1997. Characterization of expression, cytokine regulation and effector function of the high affinity receptor FcγRI (CD64) expressed on human blood dendritic cells. J. Immunol. 158:3090.
22. Gosselin, E. J., K. Wardell, D. R. Gosselin, N. Alter, J. L. Fischer, and P. M. Guyre. 1992. Enhanced antigen presentation using Fcγ receptor (monocytemacrophage)-specific immunogens. J. Immunol. 149:3477.
23. Sallutso, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
24. Simmons, D., and B. Seed. 1988. The Fcγ receptor of natural killer cells is a phospholipid-linked membrane protein. Nature 333:568.
25. Jones, D. H., R. J. Looney, and C. L. Anderson. 1985. Fcγ receptors on a human monocyte line (U937) defined by differences in binding of murine IgG subclasses at low ionic strength. J. Immunol. 135:3348.
26. Mossman, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:793.
27. Powrie, F., and R. L. Coffman. 1993. Cytokine regulation of T-cell function: a potential for therapeutic intervention. Immunol. Today 14:270.
28. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7.1 and B7.2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
29. Bankert, R. B., T. Umemoto, Y. Sugiyama, F. A. Chen, E. Repasky, and S. Yokota. 1989. Human lung tumors, patients' peripheral blood and tumor infiltrating lymphocytes propagated in scid mice. Curr. Top. Microbiol. Immunol. 152:201.
30. Watt, K. W. K., P. J. Lee, T. M'Timkulu, W. P. Chan, and R. Loor. 1986. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc. Natl. Acad. Sci. USA 83:3166.
31. Stevens, T. L., A. Bossie, V. M. Sanders, R. Fernandez-Bortran, R. L. Coffman, T. R. Mossman, and E. S. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255.
32. Lundgren, M., U. Perrson, P. Larrson, C. Magnusson, C. I. E. Smith, L. Hammarstrom, and E. Severison. 1989 Interleukin-4 induces synthesis of IgE and IgG4 in human B cells. Eur. J. Immunol. 19:1311.
33. Caux, C., B. Vanbervliet, C. Massacrier, C. Dezutter-Dambuyant, B. de Saint-Vis, C. Jacquet, K. Yoneda, S. Imamura, D. Schmitt, and J. Banchereau. 1994. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNFα. J. Exp. Med. 184:695.
34. Ritz, J., J. M. Pesando, S. E. Sallan, L. A. Clavell, J. Notis-McConarty, P. Rosenthal, and S. F. Schlossman. 1981. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood 44:5914.
35. Maloney, D. G., T. M. Liles, D. K. Czerwinski, C. Waldichuck, J. Rosenberg, A. Grillo-Lopez, and R. Levy. 1994. Phase I clinical trial using escalating dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 84:2457.
36. Lu, E. W., A. T. Bustaria, I. Royston, and P. Brams. 1993. Factors affecting production of antibodies to prostate antigens by in vitro-primed human splenocytes. Hybridoma 12:381.
37. Oesterling, J. E. 1991. Prostate specific antigen: a valuable clinical tool. Oncology 5:107.
38. Ingmar, A., F. M. Heijnen, M. J. van Gugt, N. A. Fanger, R. F. Graziano T. P. M. de Wit, F. M. A. Hofhuis, P. M. Guyre, P. J. A. Capel, J. S. Verbeek, et al. 1996. Antigen targeting to myeloid-specific human FcγRI/CD64 triggers enhanced antibody responses in transgenic mice. J. Clin. Invest. 97:331.
39. Liu, C., J. Goldstein, R. F. Graziano, H. Jai, J. K. O'Shea, Y. Deo, and P. M. Guyre. 1996. FcγRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonistic T cell epitopes. J. Clin. Invest. 98:2001.
40. Chen, F.-A., S. S. Williams, W. C. Fanslow, and R. B. Bankert 1995. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/ CD40 ligand. J. Immunol. 155:2833.
41. Porgador, A., D. Snyder, and E. Gilboa. 1996. Induction of anti-tumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156:29-18.
42. Zitvogel L., J. I. Mayordomo, T. Tjandrawan, A. B. DeLeo, M. R. Clarke, M. T. Lotze, and W. J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines J. Exp. Med. 183:87.
43. Celluzi, C. M., J. I. Mayordomo, M. T. Lotze, and L. D. Falo. 1996. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective immunity. J. Exp. Med. 183:283.
44. Boussiotis, V. A., G. J. Freeman, J. G. Gribben, J. Daley, G. Gray, and L. M. Nadler. 1993. Activated human B lymphocytes express three CTLA-4 counterreceptors that stimulate T-cell activation. Proc. Natl. Acad. Sci. USA 90: 11059.
45. Hart, D. N., G. C. Starling, V. L. Calder, and N. S. Fernando. 1993. B7/BB-1 is a leukocyte differentiation antigen on human dendritic cells induced by activation. Immunology 4:616.
46. Avraméas, A., D. McIlroy, A. Hosmalin, B. Autran, P. Debré, M. Monsigny, A. C. Roche, and P. Midoux. 1996. Expression of a mannose/fucose membrane lectin on human dendritic cells. Eur. J. Immunol. 26:394.
47. Jiang, W., W. J. Swiggard, C. Heufler, M. Peng, A. Mirza, R. M. Steinman, and N. C. Neussenzweig. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151.
48. Lu, J. 1997. Collectins: collectors of microorganisms for the innate immune system. Bioessays 19:509.
49. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X.-Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
50. DiMolfetto, L., H. A. Neal, A. Wu, C. Reilly, and D. Lo. 1998. The density of class II MHC T cell receptor ligand influences INF-γ/IL-4 ratios in immune responses in vivo. Cell. Immunol. 183:70.
51. Mossmann, T. R., and R. L. Coffman. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46:111.
52. Kitajima, T., G. Caceres-Dittmar, F. J. Tapia, J. Jester, P. R. Bergstresser, and A. Takashima. 1996. T cell-mediated terminal maturation of dendritic cells. J. Immunol. 157:2340.
53. + cells. J. Immunol. 154:5071.
54. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 186:747.
55. Heufler, C., F. Koch, U. Stanzel, G. Topar, M. Wysocka, G. Trinchieri, A. Enk, R. M. Steinman, N. Romani, and G. Schuler. 1996. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells. Eur. J. Immunol. 26:659.
56. Hino, A., and H. Nariuchi. 1996. Negative feedback mechanism suppresses interleukin-12 production by antigen presenting cells interacting with T helper 2 cells. Eur. J. Immunol. 26:623.
57. Ludewig, B., D. Graf, H. R. Gelderblom, Y. Becker, R. A. Kroczek, and G. Pauli. 1995. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur. J. Immunol. 25:1943.
58. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kämpgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: upregulation by MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741.
59. Ozawa, H., S. Aiba, S. Nakagawa, and H. Tagami. 1996. Interferon-γ and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7.1) expression. Eur. J. Immunol. 26:648.
60. Itoh, K., and S. Hirohata. 1995. The role of IL-10 in human B cell activation, proliferation, and differentiation. J. Immunol. 154:4341.